Brand Name: EPKINLY Generic Name: (epcoritamab-bysp). EPKINLY (epcoritamab-bysp) is used to treat lymphoma.
Epcoritamab-bysp is approved to treat adults with: Diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma. Follicular lymphoma.
| Brand Name: | EPKINLY |
| Generic Name: | epcoritamab-bysp |
| Strength: | • Injection: 4 mg/0.8 mL in a single-dose vial. Dilute prior to use. • Injection: 48 mg/0.8 mL in a single-dose vial. |
| Manufacturer: | Genmab US, Inc |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “EPKINLY (epcoritamab-bysp)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for EPKINLY (epcoritamab-bysp) cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
